Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application

References

• Abdel Wahab AF, Hussein AK, Khaled KA, Ahmed OAA. Meloxicam depot parenteral bio-degradable microspheres: Preparation, characterization and in-vivo evaluation. Int J Pharm Sci Rev Res, 2013;21(2):38–45.
   Google Scholar
• Ahmed OAA, Afouna MI, El-Say KM, Abdel-Naim AB, Khedr A, Banjar ZM. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches. Expert Opin Drug Deliv, 2014;11(7):1005–13.
   PubMed Web of Science ®Google Scholar
• Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release, 2001;73(1):59–74.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm, 2008;346(1-2):151–9.
   PubMed Web of Science ®Google Scholar
• Burns SA, Hard R, Hicks WL Jr, Bright FV, Cohan D, Sigurdson L, Gardella JA Jr. Determining the protein drug release characteristics and cell adhesion to a PLLA or PLGA biodegradable polymer membrane. J Biomed Mater Res A, 2010;94(1):27–37.
   PubMed Web of Science ®Google Scholar
• Caon T, Porto LC, Granada A, Tagliari MP, Silva MAS, Simoes CMO, Borsali R, Soldi V. Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride. Eur J Pharm Sci, 2014;52:165–72.
   PubMed Web of Science ®Google Scholar
• Carlucci G, Mazzeo P. Finasteride in biological fluids: Extraction and separation by a graphitized carbon black cartridge and quantification by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 1997;693:245–8.
   PubMed Web of Science ®Google Scholar
• Chen C, Puy LA, Simard J, Li X, Singh SM, Labrie F. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity organ and activity. J Invest Dermatol, 1995;105:678–82.
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, Ren J, Li X, Zou Q. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study. Clin Ther, 2009;31(10):2242–8.
   PubMed Web of Science ®Google Scholar
• Engstrom G, Henningsohn L, Steineck G, Leppert J. Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract. BJU Int, 2005;95:810–15.
   PubMed Web of Science ®Google Scholar
• Giovagnoli S, Blasi P, Ricci M, Schouben A, Perioli L, Rossi C. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation. J Pharm Sci, 2008;97:303–17.
   PubMed Web of Science ®Google Scholar
• Hariharan M, Price JC. Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine. J Microencapsul, 2002;19(1):95–109.
   PubMed Web of Science ®Google Scholar
• Jaime AY, Connie MR, Casey LS, Forrest ML, Davies NM. Flip-flop pharmacokinetics-delivering a reversal of disposition: Challenges and opportunities during drug development. Ther Deliv, 2011;2(5):643–72.
   PubMedGoogle Scholar
• Klose D, Siepmann F, Elkharraz K, Siepmann J. PLGA based drug delivery systems: Importance of the type of drug and device geometry. Int J Pharm, 2008;354:95–103.
   PubMed Web of Science ®Google Scholar
• Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: Results from the Third National Health and Nutrition Examination Survey. J Urol, 2011;185:571–7.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Colloids Surf A: Physicochem Eng Aspects, 2001;182(1–3):123–30.
   Web of Science ®Google Scholar
• Lanza R, Langer R, Vacanti J. 2007. Principles of tissue engineering. New York: Elsevier Academic Press, pp. 1265–70.
   Google Scholar
• Lu L, Garcia CA, Mikos AG. In vitro degradation of thin poly(D,L-lactic-co-glycolic acid) films. J Biomed Mater Res, 1999;46:236–44.
   PubMed Web of Science ®Google Scholar
• Malik K, Singh I, Nagpal M, Arora S. Atrigel: A potential parenteral controlled drug delivery system. Der Pharmacia Sinica, 2010;1(1):74–81.
   Google Scholar
• Marihart S, Harik M, Djavan B. Dutasteride: A review of current data on a novel dual inhibitor of 5alpha reductase. Rev Urol, 2005;7:203–10.
   PubMedGoogle Scholar
• Mehr NG, Li X, Ariganello MB, Hoemann CD, Favis BD. Poly(ɛ-caprolactone) scaffolds of highly controlled porosity and interconnectivity derived from co-continuous polymer blends: Model bead and cell infiltration behavior. J Mater Sci: Mater Med, 2014;25:2083–93.
   PubMed Web of Science ®Google Scholar
• Mittal G, Kumar MN. Impact of polymeric nanoparticles on oral pharmacokinetics: A dose-dependent case study with estradiol. J Pharm Sci, 2009;98(10):3730–4.
   PubMed Web of Science ®Google Scholar
• Mousavi SHH, Kobarfard F, Husain SW, Tehrani MS, Azar PA, Ahmadkhaniha R, Mehdizadeh A. A rapid, simple, liquid chromatographic-electrospray ionization, ion trap mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic study. Iranian J Pharm Res, 2012;11:59–67.
   PubMed Web of Science ®Google Scholar
• Nepal PR, Chun MK, Choi HK. Preparation of floating microspheres for fish farming. Int J Pharm, 2007;341:85–90.
   PubMed Web of Science ®Google Scholar
• Nojehdehian H, Ekrami M, Ansari ZJ. Loading of gentamicin sulfate into poly (lactic-co-glycolic acid) biodegradable microspheres. J Dental School, 2015;33(2):145–51.
   Google Scholar
• Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, Barrett-Connor E, Marshall LM. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int, 2009;104:63–8.
   PubMed Web of Science ®Google Scholar
• Patel DB, Patel NJ. Validated RP-HPLC and TLC methods for simultaneous estimation of tamsulosin hydrochloride and finasteride in combined dosage forms. Acta Pharm, 2010;60(2):197–205.
   PubMed Web of Science ®Google Scholar
• Qi F, Wua J, Fana Q, Hea F, Tiana G, Yanga T, Ma G, Su Z. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability. Colloids Surf B, 2013;112:492–8.
   PubMed Web of Science ®Google Scholar
• Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother, 2010;11:1295–304.
   PubMed Web of Science ®Google Scholar
• Selmin F, Blasi P, DeLuca PP. Accelerated polymer biodegradation of risperidone poly(D,L-lactide-co-glycolide) microspheres. AAPS PharmSciTech, 2012;13(4):1465–72.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: An overview. Int J Pharm, 2004;278(1):1–23.
   PubMed Web of Science ®Google Scholar
• Smith AB, Carson CC. Finasteride in the treatment of patients with benign prostatic hyperplasia: A review. Ther Clin Risk Manag, 2009;5:535–45.
   PubMedGoogle Scholar
• Sudhakar M, Kancharla RA, Rao VU. A review on sustained release injectable depot drug delivery. An Int J Adv Pharm Sci, 2013;4(2):142–58.
   PubMedGoogle Scholar
• Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials, 2004;25:5735–42.
   PubMed Web of Science ®Google Scholar
• Swamy NGN, Abbas Z. Preparation and in vitro characterization of mucoadhesive hydroxypropyl guar microspheres containing amlodipine besylate for nasal administration. Indian J Pharm Sci, 2011;73(6):608–14.
   PubMed Web of Science ®Google Scholar
• Tanigawara Y, Komada F, Shimizu T, Iwakawa S, Iwai T, Maekawa H, Hori R, Okumura K. Population pharmacokinetics of theophylline. III. Premarketing study for a once-daily administered preparation. Biol Pharm Bull, 1995;18(11):1590–8.
   PubMed Web of Science ®Google Scholar
• Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR, Beer TM, Bauer DC, Zmuda JM, Orwoll ES. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study. Urology, 2006;68:804–9.
   PubMed Web of Science ®Google Scholar
• Turncliff RZ, Dunbar JL, Dong Q, Silverman BL, Ehrich EW, Dilzer SC, Lasseter KC. Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment. J Clin Pharmacol, 2005;45(11):1259–67.
   PubMed Web of Science ®Google Scholar